• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The Effect of Probiotic Treatment on Patients Infected with the H7N9 Influenza Virus

tetano

Editor, Senior Moderator
PLoS One. 2016 Mar 17;11(3):e0151976. doi: 10.1371/journal.pone.0151976. eCollection 2016.
[h=1]The Effect of Probiotic Treatment on Patients Infected with the H7N9 Influenza Virus.[/h] Hu X[SUP]1,[/SUP][SUP]2[/SUP], Zhang H[SUP]1[/SUP], Lu H[SUP]1[/SUP], Qian G[SUP]1[/SUP], Lv L[SUP]1[/SUP], Zhang C[SUP]3[/SUP], Guo J[SUP]1[/SUP], Jiang H[SUP]1[/SUP], Zheng B[SUP]1[/SUP], Yang F[SUP]1[/SUP], Gu S[SUP]1[/SUP], Chen Y[SUP]1[/SUP], Bao Q[SUP]1[/SUP], Yu L[SUP]1[/SUP], Jiang X[SUP]1[/SUP], Hu Q[SUP]1[/SUP], Shi H[SUP]1[/SUP], Gao H[SUP]1[/SUP], Li L[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] A novel avian-origin influenza A (H7N9) virus emerged and spread among humans in Eastern China in 2013. Prophylactic treatment with antibiotics and probiotics for secondary infection is as important as antiviral treatment. This study aims to assess the ability of probiotic treatment to restore internal homeostasis under antibiotic pressure and to reduce/ameliorate the risk of secondary infections resulting from infection with the H7N9 virus.
[h=4]METHODS:[/h] This is a retrospective study in archival samples. Between April 1 and May 10, 2013, 113 stool, sputum, and blood specimens were collected and analyzed by denaturing gradient gel electrophoresis (DGGE) to determine the composition of the patient microbiomes. Microbial diversity was calculated using Gel-Pro analyzer and Past software. Cluster analysis of DGGE pattern profiles was employed to create a phylogenetic tree for each patient, and multidimensional scaling (MDS) and principal component analysis (PCA) were performed to visualize relationships between individual lanes.
[h=4]RESULTS:[/h] Five patients had secondary infections, including Klebsiella pneumonia, Acinetobacter baumanii and Candida albicans infection. The DGGE profiles of fecal samples obtained at different time points from the same individual were clearly different, particularly for patients with secondary infections. Shannon's diversity index and evenness index were lower in all infected groups compared to the control group. After B. subtilis and E. faecium or C. butyricum administration, the fecal bacterial profiles of patients who had not been treated with antibiotics displayed a trend of increasing diversity and evenness. C. butyricum failed to reduce/ameliorate secondary infection in H7N9-infected patients, but administration of B. subtilis and E. faecium appeared to reduce/ameliorate secondary infection in one patient.
[h=4]CONCLUSION:[/h] H7N9 infection might decrease intestinal microbial diversity and species richness in humans. C. butyricum failed to reduce/ameliorate secondary infection in H7N9-infected patients. B. subtilis and E. faecium may also play a role in reducing/ameliorating secondary infection in these patients.


PMID: 26987119 [PubMed - in process]
 
Back
Top Bottom